EDT Anbio Biotechnology (NNNN) trading resumesOptimize Your Investment Research with SparkEffectively assess a stock's risks and ...

EDT Anbio Biotechnology (NNNN) trading halted, volatility trading pauseOptimize Your Investment Research with SparkEffectively assess a ...

Anbio Biotechnology Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement ...

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the "Company" or "Anbio"), a global diagnostic company dedicated to the advancement of medical technology and the ...

Overview: Anbio Biotechnology specializes in providing in vitro diagnostics (IVD) products globally and has a market cap of $253.25 million. Operations: Anbio Biotechnology generates revenue ...

Anbio Biotechnology, a global medical technology company focused on in vitro diagnostics, has successfully closed its initial public offering of 1,600,000 Class A ordinary shares at a price of $5. ...

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the ...

March 7, 2025 (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces ...